Pharma Journalist 8887 posts 0 comments

Tempus AI has announced a strategic collaboration with Daiichi Sankyo to accelerate the clinical development of antibody-drug conjugates (ADCs) in oncology, highlighting the growing…
Read More...

Cognito Therapeutics has partnered with Ochsner Health to establish a new Brain Health Collaboratory aimed at advancing innovative approaches to treating cognitive decline and…
Read More...

Merck & Co.—known as MSD outside North America—has announced a definitive agreement to acquire Terns Pharmaceuticals in a deal valued at approximately $6.7 billion, strengthening…
Read More...

UCB has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP), recommending an update to the marketing authorization for…
Read More...

Japan’s Ministry of Health, Labour and Welfare has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of adults with moderate-to-severe bullous…
Read More...

Gilead Sciences has announced a definitive agreement to acquire Ouro Medicines, a privately held firm focused on developing T cell engager therapies for autoimmune diseases. The move…
Read More...

Quotient Therapeutics has entered a multi-year research collaboration with Merck & Co.—known as MSD outside the United States and Canada—to identify new drug targets for…
Read More...

Viz.ai has announced a strategic partnership with Alnylam Pharmaceuticals aimed at improving the early detection and diagnosis of cardiac amyloidosis, a serious and often underdiagnosed…
Read More...

UCB has announced plans to establish a major new biologics manufacturing facility in Gwinnett County, Georgia, marking a significant step in the company’s long-term U.S. expansion…
Read More...

Zealand Pharma has announced plans to establish a new research hub in Cambridge, Massachusetts, marking a significant expansion of its global footprint and reinforcing its ambitions in…
Read More...